MENUNews Archive
Date: 01/19/2022
A mutated gene affects growth of brain tumor cells in young adults, indicating sensitivity to a new treatment strategy, a team of researchers at the Rogel Cancer Center discovered. These findings, recently published in Cell Reports, present possibilities for more effective therapies for glioma patients with this gene mutation.
Date: 01/13/2022
A $7.6 million gift from Judith L. Tam and the Richard Tam Foundation has launched an accelerated research initiative here at the Rogel Cancer Center to understand why alterations in the ALK gene causes lung cancer to become resistant to standard therapy over time.
Date: 12/17/2021
The Ronald Weiser Center for Prostate Cancer will aim to elevate and optimize the health care experience for patients with prostate cancer and their families.
Date: 12/03/2021
Inside our cells is a complex networks of signals, proteins that need to get to the right place at the right time. And to get there, many rely on a type of protein called kinesins. A study led by the University of Michigan has uncovered unexpected details about a key regulator of this cellular traffic.
Date: 12/03/2021
The University of Michigan Health Rogel Cancer Center has earned a three-year accreditation from the National Accreditation Program for Rectal Cancer, a quality program of the American College of Surgeons’ Commission on Cancer. This recognition signals advanced technical expertise and multidisciplinary care for rectal cancer.
Date: 12/03/2021
The 63rd American Society of Hematology Annual Meeting and Exposition runs Dec. 11-14, 2021, both in-person in Atlanta, Georgia, and virtually. Rogel Cancer Center members will present about 30 sessions, beginning with pre-conference workshops on Dec. 8.
Date: 11/23/2021
A new study from the University of Michigan Health Rogel Cancer Center finds circulating tumor DNA, or ctDNA, levels can predict as early as two weeks after starting treatment which patients are likely to have good outcomes.
Date: 11/16/2021
New research finds fewer than one-third of hospitals had immediate availability of a crucial blood cancer medication called all-trans retinoic acid (ATRA). ATRA is initiated early in the treatment of acute promyelocytic leukemia to prevent major bleeding, clotting and potential death.
Date: 11/15/2021
When a computer optimized the treatment plan for radiation therapy that was broken into multiple segments, known as inverse-planned, intensity-modulated radiotherapy, or IMRT, breast cancer patients were in less pain and experienced less skin irritation than when CT scans were used to deliver three-dimensional conformal radiation therapy, also know as 3DCRT.
Date: 11/02/2021
When they are not fighting off diseases and infections, immune T cells can sometimes turn on the gastrointestinal system, causing problems such as autoimmune inflammatory bowel disease, graft-vs.-host disease from a bone marrow transplant or colitis from cancer immune checkpoint blocker therapies.